Botzenhardt Florian, Eichinger Walter B, Bleiziffer Sabine, Guenzinger Ralf, Wagner Ina M, Bauernschmitt Robert, Lange Ruediger
Department of Cardiovascular Surgery, German Heart Center-Munich, Munich, Germany.
J Am Coll Cardiol. 2005 Jun 21;45(12):2054-60. doi: 10.1016/j.jacc.2005.03.039.
The present study evaluates complete supra-annular bioprostheses in patients with an aortic annulus of 18 to 23 mm in diameter.
Aortic valve replacement in patients with small aortic annulus using stented bioprostheses is often associated with unsatisfactory hemodynamic results and high incidence of patient-prosthesis mismatch.
Between February 2000 and January 2004, 156 patients with aortic valve disease and an aortic annulus of 18 to 23 mm in diameter received the stented bovine Soprano (Sorin Biomedica Cardio, Saluggia, Italy) (n = 18), Perimount (Edwards Lifesciences, Irvine, California) (n = 52), Perimount Magna (Edwards Lifesciences) (n = 42), or the stented porcine Mosaic (Medtronic Inc., Minneapolis, Minnesota) (n = 44) bioprostheses. Intraoperatively, the surgeon measured the aortic annulus diameter by inserting a hegar dilator. Thus, postoperative hemodynamic results could be referred to the patient's aortic annulus diameter instead of referring the results to the labeled valve size. This allows for objective comparisons between different valve types.
There was no significant difference in hemodynamic results between the different valve types in patients with an aortic annulus 18 to 20 mm. In patients with an annulus 21 to 23 mm, the Magna was significantly superior to the other investigated devices in mean pressure gradient, effective orifice area, and incidence of patient-prosthesis mismatch. There was no significant difference between the complete supra-annular bioprostheses Mosaic and Soprano and the intra-supra-annular Perimount valve.
In patients with an aortic annulus of 18 to 20 mm in diameter, hemodynamic performance is independent of the implanted stented valve type and the annular position. Root enlargement or stentless valves may be beneficial alternatives. Patients with annulus diameter 21 to 23 mm benefit from the Magna in complete supra-annular position leading to superior hemodynamic results.
本研究评估直径为18至23毫米主动脉瓣环患者使用的完整超环生物瓣膜。
使用带支架生物瓣膜对小主动脉瓣环患者进行主动脉瓣置换术,常常伴有血流动力学结果不理想以及患者-假体不匹配发生率高的情况。
在2000年2月至2004年1月期间,156例患有主动脉瓣疾病且主动脉瓣环直径为18至23毫米的患者接受了带支架的牛Soprano(索林生物医学心脏公司,意大利萨卢贾)(n = 18)、Perimount(爱德华兹生命科学公司,加利福尼亚州欧文)(n = 52)、Perimount Magna(爱德华兹生命科学公司)(n = 42)或带支架的猪Mosaic(美敦力公司,明尼苏达州明尼阿波利斯)(n = 44)生物瓣膜。术中,外科医生通过插入海格扩张器测量主动脉瓣环直径。因此,术后血流动力学结果可参照患者的主动脉瓣环直径,而非参照标记的瓣膜尺寸。这使得不同瓣膜类型之间能够进行客观比较。
在主动脉瓣环为18至20毫米的患者中,不同瓣膜类型之间的血流动力学结果无显著差异。在瓣环为21至23毫米的患者中,Magna在平均压力阶差、有效瓣口面积和患者-假体不匹配发生率方面显著优于其他所研究的器械。完整超环生物瓣膜Mosaic和Soprano与环内超环Perimount瓣膜之间无显著差异。
对于主动脉瓣环直径为18至20毫米的患者,血流动力学性能与植入的带支架瓣膜类型及瓣环位置无关。根部扩大术或无支架瓣膜可能是有益的替代方案。瓣环直径为21至23毫米的患者在完整超环位置使用Magna可获得更好的血流动力学结果。